Clinical Trials Browser

OTHER × Recurrence × cabozantinib × Clear all

NCT04204850 2025-12-03

Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT06156410 2025-11-14

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

Phase 1 Recruiting

Recurrence, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT01866293 2017-08-30

Cabozantinib (XL184) in Patients With Relapsed or Refractory Myeloma

Phase 1/2 Completed

11 enrolled 12 charts

Multiple Myeloma, Recurrence